ACLARION, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
ACLARION, INC. (ACON) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 711.87 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06
- ACLARION, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 789.23K shares, a 2387.56% increase year-over-year.
- ACLARION, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 31.73K shares, a 2546.12% increase year-over-year.
- ACLARION, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 1.20K shares, a 99.70% decline year-over-year.
- ACLARION, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 404.86K shares, a 92.75% decline year-over-year.
- ACLARION, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 62.98K shares, a 3565.77% increase from fiscal 2024.
- ACLARION, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 1.72K shares, a 3141.51% increase from fiscal 2023.
- ACLARION, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 53.00 shares, a 99.99% decline from fiscal 2022.
- ACLARION, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 355.10K shares, a 90.20% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 711.87K shares 10-Q · filed 2026-08-06 | |||||||
| 2026-03-31 | 789.23K shares 10-Q · filed 2026-05-13 | |||||||
| 2025-12-31 | 62.98K shares 10-K · filed 2026-03-18 | |||||||
| 2025-09-30 | 25.62K shares 10-Q · filed 2025-11-12 | |||||||
| 2025-06-30 | 25.73K shares 10-Q · filed 2026-08-06 | 19.73K shares 10-Q · filed 2025-08-14 | ||||||
| 2025-03-31 | 31.73K shares 10-Q · filed 2026-05-13 | |||||||
| 2024-12-31 | 1.72K shares 10-K · filed 2026-03-18 | |||||||
| 2024-09-30 | 1.32K shares 10-Q · filed 2025-11-12 | 11.94M shares 10-Q · filed 2024-11-14 | ||||||
| 2024-06-30 | 1.20K shares 10-Q · filed 2025-08-14 | 10.84M shares 10-Q · filed 2024-08-14 | ||||||
| 2024-03-31 | 1.20K shares 10-Q · filed 2025-05-15 | 10.85M shares 10-Q · filed 2024-05-15 | ||||||
| 2023-12-31 | 53.00 shares 10-K · filed 2025-04-09 | 475.49K shares 10-K · filed 2024-03-28 | ||||||
| 2023-09-30 | 7.33M shares 10-Q · filed 2024-11-14 | |||||||
| 2023-06-30 | 434.36K shares 10-Q · filed 2024-08-14 | 6.95M shares 10-Q · filed 2023-08-25 | ||||||
| 2023-03-31 | 404.86K shares 10-Q · filed 2024-05-15 | 6.48M shares 10-Q · filed 2023-07-03 | ||||||
| 2022-12-31 | 355.10K shares 10-K · filed 2024-03-28 | 5.68M shares 10-K · filed 2023-02-27 | ||||||
| 2022-09-30 | 5.62M shares 10-Q · filed 2022-11-14 | 5.58M shares 10-Q · filed 2023-11-14 | 5.59M shares 10-Q · filed 2022-11-14 | |||||
| 2022-06-30 | 5.54M shares 10-Q · filed 2022-08-15 | 5.56M shares 10-Q · filed 2023-08-25 | 5.57M shares 10-Q · filed 2022-08-15 | |||||
| 2022-03-31 | 5.59M shares 10-Q · filed 2023-07-03 | 5.61M shares 10-Q · filed 2022-06-06 | ||||||
| 2021-12-31 | 3.62M shares 10-K/A · filed 2023-06-12 | |||||||
| 2021-09-30 | 3.56M shares 10-Q · filed 2022-11-14 | 3.13M shares 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | 2.92M shares 10-Q · filed 2022-08-15 | 2.92M shares 10-Q · filed 2022-08-15 | ||||||
| 2021-03-31 | 2.92M shares 10-Q · filed 2022-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |